Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 28, 2014; 20(44): 16665-16673
Published online Nov 28, 2014. doi: 10.3748/wjg.v20.i44.16665
Published online Nov 28, 2014. doi: 10.3748/wjg.v20.i44.16665
Figure 1 Estradiol and ER selective agonists impair cell proliferation in human LoVo cells.
A: Structures of 17β-estradiol, propylpyrazole-triol (PPT), a selective agonist of ERα, and diarylpropionitrile (DPN), a selective agonist of ERβ; B: LoVo cells cultured in DMEM were treated with 17β-estradiol, PPT and DPN for 24 h and 48 h and were then analyzed for cell viability by the MTT assay. aP < 0.05 vs control; bP < 0.001 vs control (means ± SE, n = 3).
- Citation: Hsu HH, Kuo WW, Ju DT, Yeh YL, Tu CC, Tsai YL, Shen CY, Chang SH, Chung LC, Huang CY. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53. World J Gastroenterol 2014; 20(44): 16665-16673
- URL: https://www.wjgnet.com/1007-9327/full/v20/i44/16665.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i44.16665